Back to index
VeriSIM Life

VeriSIM Life

verisimlife.comDrug Discovery and Development

What AI says about VeriSIM Life

VeriSIM Life utilizes AI to enhance drug discovery and development processes, aiming to improve patient outcomes by predicting the success of drug candidates. Their innovative platform, BIOiSIM, allows for advanced simulations and insights, minimizing waste and inefficiencies in drug development.

Is this your brand?

Claim this profile to keep your information accurate and add what's missing.

Products & Services

BIOiSIM

An AI-driven decision engine that facilitates drug discovery and R&D de-risking through predictive analytics and simulation capabilities.

PulmoSIM Therapeutics

A service that identifies licensable candidates for preclinical translation and out-licensing to commercialization partners.

Common Questions

What is BIOiSIM?

BIOiSIM is an AI-driven platform that accelerates drug discovery by providing predictive analytics and simulation capabilities for drug candidates.

Who can benefit from VeriSIM Life's services?

VeriSIM Life's services are designed for pharmaceutical companies, biotechs, and academic research institutions looking to enhance their drug development processes.

What is the mission of VeriSIM Life?

The mission of VeriSIM Life is to eliminate inaccuracy and waste in drug development, ensuring that promising drug candidates are identified and advanced efficiently.

When was VeriSIM Life founded?

VeriSIM Life was founded in 2017.

Where is VeriSIM Life located?

VeriSIM Life is headquartered in San Francisco, CA.

Company Information

Founded
2017
Headquarters
San Francisco, CA
Employees
51-200
Industries
AIPharmaceuticalsDrug Development